Logout Login Cart iconShop Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "artesyn"

Looking for quality documents?
webpage icon
ARTeSYN joins Repligen
Repligen and ARTeSYN now provide best-in-class single-use bioprocessing systems and industry-leading filtration and chromatography solutions.
publications icon
Artesyn Chromatography Systems Data Sheet
video icon
ARTeSYN and Repligen are now one
Together, Repligen and ARTeSYN now provide best-in-class single-use bioprocessing systems and industry-leading filtration and chromatography solutions. Single-use TFF Systems Single-use Viral Filtration Systems Single-use Final Filtration and Bulk Filling Systems Single-use Chromatography Systems
webpage icon
Locations
View contact information for Repligen offices and facilities globally.
event icon
Advanced chromatography system design increases yield and reduces deviations
The newly designed Artesyn Chromatography Systems from Repligen execute processes with improved yield, reproducibility, and operational simplicity. Over-molded tubing connections eliminate the use of hose barbs and zip ties, which are prone to leaking. Synergistic multi-valve manifolds create a streamlined liquid path without small crevices that typically cause carry-over between buffers. Batch change-overs can be made in under 30 minutes with no tools. The positive impact on process yield and facility output will be discussed.
news icon
Repligen strengthens downstream offering with $200m ARTeSYN acquisition
external link icon
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
Proposed A RTeSYN a cquisition adds gold standard single - use downstream bioprocessing s ystems
Advances Repligen’s S ystems strategy in Filtration and Chromatography , c omplement ing TangenX ® F lat S heet cassettes and OPUS ® PP C Completes acquisition of Non-Metallic Solutions (NMS), complementing our recent acquisition of EMT and further strengthens our single-use flow paths, durable plastics and assembly portfolio
WALTHAM, Mass., Oct. 27, 2020 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a definitive agreement to acquire privately-held ARTeSYN Biosolutions (“ARTeSYN”) for approximately $200 million, comprised of approximately $130 million in cash and approximately $70 million in Repligen common stock. ARTeSYN Biosolutions is projected to generate approximately $30 million in revenue (pro forma) in 2020, led by the success of its
news icon
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
external link icon
Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
Reports record quarterly revenue of $94.1 million with strong margin expansion
Overall revenue grew 35% year-over-year, with organic growth of 31% Raises revenue guidance to $ 348 -$ 352 million and overall revenue growth to 29%-30% for full year 2020, representing 23 %- 24 % organic growth Completes acquisition of Non-Metallic Solutions and an nounces a greement to a cquire b ioprocess s ystems i nnovator ARTeSYN Biosolutions WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its third quarter of 2020. Provided in this press release are financial highlights for the three- and nine- month periods ended September 30, 2020, updates to our financial guidance for the fiscal year 2020 and access information for today’s webcast and conference call. Tony J. Hunt, President and Chief Executive Officer said, “We are pleased with our momentum